Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,037 | 17,116 | 21,050 | 13,376 | 13,471 |
| TOTAL | $11,643 | $17,943 | $22,313 | $14,916 | $16,837 |
| Non-Current Assets | |||||
| PPE Net | 801 | 872 | 943 | 800 | 859 |
| Other Non-Current Assets | 23 | 23 | 23 | 24 | 23 |
| TOTAL | $824 | $895 | $966 | $824 | $882 |
| Total Assets | $12,467 | $18,838 | $23,279 | $15,740 | $17,719 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,493 | 2,020 | 1,097 | 1,723 | 3,796 |
| Accrued Expenses | 2,074 | 3,600 | 3,676 | 2,959 | 2,921 |
| Other current liabilities | 1,520 | 4,173 | 12,752 | 7,648 | 9,771 |
| TOTAL | $5,087 | $9,793 | $17,525 | $12,330 | $16,488 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,499 | 12,493 | 12,426 | 508 | 682 |
| TOTAL | $12,489 | $12,455 | $12,418 | $448 | $470 |
| Total Liabilities | $17,576 | $22,248 | $29,943 | $12,778 | $16,958 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15 | 15 | 15 | 15 | 14 |
| Common Shares | 129 | 4 | 129 | 128 | 118 |
| Retained earnings | -196,545 | -194,170 | -196,959 | -179,135 | -174,880 |
| Other shareholders' equity | -1,923 | -1,914 | -1,876 | -1,868 | -1,808 |
| TOTAL | $-5,109 | $-3,410 | $-6,664 | $2,962 | $761 |
| Total Liabilities And Equity | $12,467 | $18,838 | $23,279 | $15,740 | $17,719 |